Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery
Authors Dorniani D, Hussein MZ, Kura AU, Fakurazi S, Halim Shaari A, Ahmad Z
Received 8 July 2012
Accepted for publication 31 August 2012
Published 12 November 2012 Volume 2012:7 Pages 5745—5756
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Dena Dorniani,1 Mohd Zobir Bin Hussein,1,2 Aminu Umar Kura,3 Sharida Fakurazi,3 Abdul Halim Shaari,4 Zalinah Ahmad5
1Chemistry Department, Faculty of Science, 2Advanced Materials and Nanotechnology Laboratory, Institute of Advanced Technology, 3Vaccines and Immunotherapeutics Laboratory, 4Physics Department, Faculty of Science, 5Chemical Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia
Background and methods: Magnetic iron oxide nanoparticles were prepared using a sonochemical method under atmospheric conditions at a Fe2+ to Fe3+ molar ratio of 1:2. The iron oxide nanoparticles were subsequently coated with chitosan and gallic acid to produce a core-shell structure.
Results: X-ray diffraction demonstrated that the magnetic nanoparticles were pure Fe3O4 with a cubic inverse spinel structure. Transmission electron microscopy showed that the Fe3O4 nanoparticles were of spherical shape with a mean diameter of 11 nm, compared with 13 nm for the iron oxide-chitosan-gallic acid (FCG) nanocarriers.
Conclusion: The magnetic nanocarrier enhanced the thermal stability of the drug, gallic acid. Release of the active drug from the FCG nanocarrier was found to occur in a controlled manner. The gallic acid and FCG nanoparticles were not toxic in a normal human fibroblast (3T3) line, and anticancer activity was higher in HT29 than MCF7 cell lines.
Keywords: magnetic nanoparticles, chitosan, superparamagnetic, controlled-release, gallic acid, drug delivery
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]